Search details
1.
Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial.
Clin Infect Dis
; 78(3): 582-590, 2024 03 20.
Article
in English
| MEDLINE | ID: mdl-37992203
2.
Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugs.
Liver Int
; 42(6): 1268-1277, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35362660
3.
[Transjugular intrahepatic portosystemic shunt for portal hypertension] / Transjugulær intrahepatisk portosystemisk shunt ved portal hypertensjon.
Tidsskr Nor Laegeforen
; 142(14)2022 10 11.
Article
in Norwegian
| MEDLINE | ID: mdl-36226423
4.
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).
PLoS Med
; 18(6): e1003653, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34061883
5.
Hepatitis C reinfection in former and active injecting drug users in Belgium.
Harm Reduct J
; 18(1): 102, 2021 10 12.
Article
in English
| MEDLINE | ID: mdl-34641896
6.
Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.
J Hepatol
; 72(4): 643-657, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31785345
7.
Treatment completion and SVR in the context of HCV elimination: Time to let go of the reins?
Clin Infect Dis
; 2024 Jun 02.
Article
in English
| MEDLINE | ID: mdl-38824443
8.
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination.
Clin Infect Dis
; 69(12): 2218-2227, 2019 11 27.
Article
in English
| MEDLINE | ID: mdl-31352481
9.
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
Liver Int
; 39(1): 20-30, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30157316
10.
The relationship between IFNL4 genotype and the rate of fibrosis in hepatitis C patients.
Scand J Gastroenterol
; 54(9): 1172-1175, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31479286
11.
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
BMC Infect Dis
; 19(1): 943, 2019 Nov 08.
Article
in English
| MEDLINE | ID: mdl-31703669
12.
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe.
J Hepatol
; 68(3): 402-411, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29080808
13.
Increased hope following successful treatment for hepatitis C infection.
J Adv Nurs
; 74(3): 724-733, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-29082540
14.
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
BMC Infect Dis
; 17(1): 420, 2017 06 13.
Article
in English
| MEDLINE | ID: mdl-28610605
15.
HCV epidemiology in high-risk groups and the risk of reinfection.
J Hepatol
; 65(1 Suppl): S33-S45, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27641987
16.
Hepatitis C reinfection after sustained virological response.
J Hepatol
; 64(5): 1020-1026, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26780289
17.
Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs.
Int J Drug Policy
; 123: 104279, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38061225
18.
Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study.
Subst Abuse Treat Prev Policy
; 19(1): 21, 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38532435
19.
[Elimination of hepatitis C is possible]. / Eliminasjon av hepatitt C er mulig.
Tidsskr Nor Laegeforen
; 138(7)2018 04 17.
Article
in Norwegian
| MEDLINE | ID: mdl-29663789
20.
Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study.
Int J Drug Policy
; 116: 104044, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37149914